Climb Bio, Inc. (CLYM) stock

CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30

$10.36−0.51 (-4.69%)

Close on Nov 13, 2026Market cap $595.04MP/E –Yield –

Climb Bio statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 4, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $595.04M; $272.32M
Enterprise Value: $389.62M; $146.23M
PB Ratio: 2.61; 2.00
P/TBV Ratio: 2.61; 2.22

Share statisticsIndustry

Shares Outstanding: 57M; 58M
Shares Change (YoY): 8.19%; 10.8%
Shares Change (QoQ): 0.51%; 0.50%
Float: 30M; 49M
Shares Held by Insiders: 47.5%; 11.7%
Shares Held by Institutions: 98.1%; 56.4%

Short sellingIndustry

Short Interest: 11M; –
Short Interest Change: 8.45%; -0.80%
Short % of Float: 35.2%; 9.01%
Short % of Shares Outstanding: 18.5%; 6.30%
Days to Cover: 7.76; 5.15

Stock price statisticsIndustry

52-Week High: $18.33; –
52-Week Low: $1.64; –
20-Day Moving Average: $10.27; –
50-Day Moving Average: $11.58; –
200-Day Moving Average: $10.67; –
Average True Range (14): $0.95; –
Price Change (1 Week): 0.68%; -1.15%
Price Change (1 Month): -5.04%; -4.87%
Price Change (3 Months): -40.6%; -21.0%
Price Change (6 Months): -4.07%; -20.6%
Price Change (YTD): 159.0%; -23.6%
Price Change (1 Year): 439.6%; -22.4%
Price Change (3 Years): 309.5%; -29.5%
Price Change (5 Years): -42.3%; -77.9%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.50; 0.70
Relative Strength Index (14): 47.5; 43.4
Volatility (1 Year): 97.3%; 80.1%
Beta (5 Years): 0.49; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -29.3%; -49.9%
Return on Assets (ROA): -28.3%; -40.6%
Return on Invested Capital (ROIC): -93.6%; -32.9%
Return on Capital Employed (ROCE): -29.2%; -37.9%

Financial positionIndustry

Current Ratio: 26.58; 3.30
Quick Ratio: 25.98; 2.39

EfficiencyIndustry

Profits Per Employee: -$2.12M; -$689.41K
Employee Count: 28; 74
WACC: 7.60%; 10.2%

Income statement (TTM)Industry

Operating Income: -$66.76M; -$21.37M
Net Income: -$59.31M; -$22.35M
EBITDA: -$66.46M; -$17.21M
EPS (Diluted): -$0.82; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $205.42M; $68.68M
Net Cash (Debt): $205.42M; $17.76M
Net Cash Per Share: $3.58; $0.80
Equity (Book Value): $228.05M; $53.89M
Book Value Per Share: $3.97; $1.50
Tangible Book Value: $228.05M; $27.13M
Working Capital: $202.24M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$52.56M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -9.97%; -21.8%

Scores and fair valueIndustry

Altman Z-Score: 40.08; 0.23
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CLYM	S&P 500	Difference	CLYM per year	S&P 500 per year
1 month	+0.5%	-3.0%	+3.5 pts
3 months	-29.7%	-2.8%	−26.9 pts
Year to date	+159.0%	+11.5%	+147.5 pts
1 year	+454.0%	+13.5%	+440.5 pts
3 years	+303.1%	+77.7%	+225.4 pts	+59.2%	+21.1%
5 years	-42.3%	+72.6%	−114.9 pts	-10.4%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

11M CLYM shares were sold short on Oct 30, 2026, up 8.5% from the previous report, or 35.23% of the shares available to trade. At recent volumes it would take 7.8 days to buy them back. Over the last 20 sessions, 46.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	10,614,602	+8.5%	1,367,458	7.8
Oct 15, 2026	9,787,492	+0.7%	946,178	10.3
Sep 30, 2026	9,718,558	+14.2%	1,721,631	5.6
Sep 15, 2026	8,508,354	+16.5%	1,880,063	4.5
Aug 31, 2026	7,300,939	-3.4%	1,233,693	5.9
Aug 14, 2026	7,557,264	+7.4%	1,199,851	6.3
Jul 31, 2026	7,037,695	+2.4%	1,042,214	6.8
Jul 15, 2026	6,871,210	+34.8%	1,361,582	5.0
Jun 30, 2026	5,096,670	+69.8%	1,725,662	3.0
Jun 15, 2026	3,001,897	+57.3%	1,530,335	2.0
May 29, 2026	1,908,617	-8.7%	676,327	2.8
May 15, 2026	2,090,647	+17.7%	972,970	2.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?